Petros is a Men’s Health pharmaceutical company that aims to develop complementary therapeutics designed for a man’s journey, often, we believe, centered around the ones he loves and lives for. Petros aims to revolutionize the art and science behind the way men approach their health emphasizing the critical elements of medication adherence, tolerability, preservation of organic function and the restoration of vitality.
Each element approached within an integrated and interdependent perspective, targeting tangible enhancements to their health outcomes. Ultimately, Petros seeks to establish new foundations to Men’s Health that center around the whole of a man’s life and function.
|Dec 22, 2021||Petros Pharmaceuticals Announces $7.5 Million Offering|
|Dec 08, 2021||Petros Pharmaceuticals Announces Positive Over-the-Counter (OTC) Label Comprehension Study Results for Erectile Dysfunction Drug STENDRA® (avanafil)|
|Dec 02, 2021||Petros Pharmaceuticals to Present at the Benzinga Global Small Cap Conference|
|Nov 30, 2021||Petros Pharmaceuticals Announces $10 Million Offering|
|Nov 15, 2021||Petros Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update|